期刊文献+

人卵巢上皮癌组织中树突状细胞表型抗原的免疫组织化学研究 被引量:5

THE IMMUNOHISTOCHEMICAL STUDY OF DENDRITIC CELL PHENOTYPIC ANTIGENS IN HUMAN OVARIAN EPITHELIAL CARCINOMA
暂未订购
导出
摘要 目的 :观察人卵巢上皮癌中CD1c、S 1 0 0树突状阳性细胞数和表达强度及癌局部微环境中细胞表型抗原的变化 ,探讨其与卵巢上皮癌发生、发展的关系 ,为临床生物治疗提供实验依据。方法 :采用ABC免疫组织化学技术和图像分析。结果 :在卵巢上皮癌中 ,CD1c+ 、S 1 0 0 + 细胞数明显减少 ,与正常卵巢组织相比较具有显著性差异 ,与临床分期和病理分级无关 ;卵巢上皮癌中D1c、S 1 0 0阳性细胞表达强度与正常卵巢组织相比较明显减弱 ,具有显著性差异 (P <0 .0 1 ) ,与临床分期和病理分级相关。结论 :人卵巢上皮癌局部微环境中 ,树突状细胞表型抗原表达总量下降 ,说明树突状细胞在抗卵巢上皮癌的免疫应答中具有重要作用。 Objective: To investigate the number and distribution of dendritic cells and the expression of CD 1c , S-100 in different human ovarian carcinoma tissues. The number of positive cells and the expressive intensity of these antigens may illustrate the phenotypic antigen changes in the local microenvironment of ovarian carcinoma, the relationship between them and the mechanism of development. The study may provide the experimental data for the further biological therapy of ovarian carcinoma. Methods: ABC Immunocytochemistry and Computer imaging techniques were used in the experiment. Results: The results showed that the number of positive dendritic cells in ovarian carcinoma reduced greatly, which was not influenced by the clinical stages or pathological grades. While the expressive intensity of CD 1c , S-100 was weaker in ovarian carcinoma than in normal ovarian tissues, which were related with clinical stages and pathologic grades. Conclusion: It is very likely that the total expression of dendritic cell phenotypic antigens is reduced in local microenvironment of ovarian epithelial carcinoma, which may play an important role in initiating auto-immunity against ovarian cacinoma. These may be useful for the clinical appliation of passive immunity treatment in the ovarian epithelial carcinoma.
出处 《解剖学杂志》 CAS CSCD 北大核心 2001年第1期51-58,共8页 Chinese Journal of Anatomy
关键词 卵巢上皮癌 树突状细胞 免疫组织化学 表型抗原 ovary ovarian carcinoma dendritic cell immunohistochemistry
  • 相关文献

参考文献11

  • 1[1]King PD, Katz DR. Mechanisms of dendritic cell function, ImmunolToday, 1990 11: 206.
  • 2[2]Struck D, Nemeth P, EIbe A, et a1. Sunscreens protect epidermal Langerhans cells and Thy4+ cells but local contact sensitization from the effects of ultra-violet light. J Invest Dermatol, 1994, 102:525.
  • 3[3]CastanoAR, Tangri S, MillerJEW; etal. Peptide binding and presentation by mouse CD1. Science,1995, 269: 223.
  • 4[4]Thomssen H, Ivanyi J, EspitiaC, et a1. Human CD4+CD8-αβ T cell receptor T cells recognize different mycobacteria strains in the context of CD1b.Immunology, 1995, 855: 33.
  • 5[5]Brossart P, Bevan MJ. Presentation of exogenous protein antigens on major histocompatibility complex class I molecules by dendritic cells: pathway of presentation and regulation by cytokines. BLood,1997, 90(4): 1594.
  • 6[6]JuliusM, Maroun CR, Haughn L. Distinct roles for CD4 and CD8 as coreceptors in antigen receptor signaling. Immunol Today, 1993, 14: 177.
  • 7[7]Mathida M, Amos T, George K, et al. Familial clustering of malignant germ cell Tumors and langerhans histocytosis. J Clin Pathol, 1995, 48:963.
  • 8[8]Ng WK, Lam KY, Ng IOL. Langerhans cell histocytosis: Posssible association with malignant germ cell tumor. J Clin Pathol, 1995, 48: 963.
  • 9[9]Tsujitani S, Furukawa T, Ruichiro T, et al.Langerhans cells and prognosis in patients with gastric carcinoma. Cancer, 1987, 59: 501.
  • 10[10]Tay SK, Jenkins D, Maddox P, et al.Subpopubation of Langerhans cells in cervicalneoplasia. Br J Obstet Gynaecol, 1987, 94: 10.

同被引文献38

  • 1曲鹏,唐军民.树突状细胞—郎格罕氏细胞与抗肿瘤[J].解剖科学进展,1997,3(1):13-18. 被引量:1
  • 2徐丛剑,许秀兰,张惜阴,郭忠,丰有吉,金志军,曹斌融,顾健人.逆转录病毒介导Ⅰ型单纯疱疹病毒胸腺嘧啶核苷激酶基因转导卵巢癌细胞的研究[J].中华妇产科杂志,1996,31(11):664-666. 被引量:9
  • 3Yazawa K, Fisher W E, Brunicardi F C. Current progress in suicide gene therapy for cancer [J] .World J Surg,2002;26(7) :783.
  • 4Gong J, Nikrui N, Chen D et al.Fusions of human ovarian carcinoma cells with autologous or allogeneic dendritic cells induce antitumor immunity[J]. J Immunol,2000; 165(3) : 1705.
  • 5Phan V, Errington F, Cheong S C et al, A new genetic method to generate and isolate small, short-lived but highly potent dendritic cell-tumor cell hybrid vaccines [J]. Nat Med,2003 ;9(9) : 1215.
  • 6Xia J,Tanaka Y, Koido S et al, Prevention of spontaneous breast carcinoma by prophylactic vaccination with dendritic/tumor fusion ceils [J]. J Immunol, 2003 ; 170: 1980.
  • 7Inaba K,Inaba M, Romani N et al. Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/marophage colony-stimulating factor [J]. J Exp Med, 1992; 176(16) : 1693.
  • 8Gong J, CherL D, Kashlwaba M et al. Induction of antitumor activity by immunization with fusions of dendritic and carcinoma ceils [J]. Nat Med,1997;3(5) :558.
  • 9Liu Y,Zhang W, Chan T et al. Engineered fusion hybrid vaccine of IL-4 gene-modified myeloma and relative mature dendritic cells enhances antitumor immunity [J] .Leuk Res,2002;26(8):757.
  • 10Gottffied E, Krieg R, Eichelberg C et al. Characterization of cells prepared by dendritic cell-tumor cell fusion [J]. Cancer Immun,2002;2:15.

引证文献5

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部